This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Syngene has made two significant investments recently — in peptide synthesis and ADC bioconjugation. What do these moves say ...
A new study highlights a promising path toward sustainable hydrogen peroxide production using sunlight, oxygen, and water, ...
5dOpinion
Why Does A.I. Write Like … That?
It doesn’t open up the tapestry of human experience — it reads like it was written by a shut-in with Wi-Fi and a thesaurus.
Cambridge life science business AbOliGo, which is supporting researchers in spatial and single-cell analysis worldwide, has ...
New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.
The problem of antibiotic resistance gene (ARG) pollution in the environment has become one of the most severe public health ...
It doesn’t open up the tapestry of human experience — it reads like it was written by a shut-in with Wi-Fi and a thesaurus.
On5, 2025, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback